Schäfer, Philipp Sven Lars
Dimitrov, Daniel
Villablanca, Eduardo J. http://orcid.org/0000-0001-9522-9729
Saez-Rodriguez, Julio
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SPP 2395)
EC | Horizon 2020 Framework Programme (860329 Marie-Curie ITN “STRATEGY-CKD”)
Article History
Received: 31 May 2023
Accepted: 16 January 2024
First Online: 27 February 2024
Competing interests
: J.S.-R. reports funding from GSK, Pfizer and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Pfizer, Owkin and Grunenthal. E.J.V. has received research grants from F. Hoffmann-La Roche. All other authors declare no competing interests.